학술논문

Results of a Phase 2 Study of MEDI-551 and Bendamustine Vs Rituximab and Bendamustine in Relapsed or Refractory Chronic Lymphocytic Leukemia
Document Type
Abstract
Source
In Blood 6 December 2014 124(21):4472-4472
Subject
Language
ISSN
0006-4971